The effect of renal denervation on kidney oxygenation as determined by BOLD MRI in patients with hypertension
暂无分享,去创建一个
E. Vink | A. Boer | W. Verloop | W. Spiering | M. Voskuil | E. Vonken | J. Hoogduin | T. Leiner | M. Bots | P. Blankestijn
[1] S. Umemura,et al. Antihypertensive Effects and Pharmacokinetics of Single and Consecutive Administration of Doxazosin in Patients with Mild to Moderate Essential Hypertension , 1987, Journal of cardiovascular pharmacology.
[2] M. Koss,et al. A limited renal injury may cause a permanent form of neurogenic hypertension. , 1998, American journal of hypertension.
[3] B. Waeber,et al. Clinical value of ambulatory blood pressure monitoring in the assessment of antihypertensive therapy. , 1999, Blood pressure monitoring.
[4] F. Epstein,et al. Effects of furosemide on medullary oxygenation in younger and older subjects. , 2000, Kidney international.
[5] W. Welch. INTRARENAL OXYGEN AND HYPERTENSION , 2006, Clinical and experimental pharmacology & physiology.
[6] Pottumarthi V. Prasad,et al. Evaluation of Intra-Renal Oxygenation by BOLD MRI , 2006, Nephron Clinical Practice.
[7] A. Dominiczak,et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.
[8] Sean B Fain,et al. BOLD-MRI assessment of intrarenal oxygenation and oxidative stress in patients with chronic kidney allograft dysfunction. , 2007, American journal of physiology. Renal physiology.
[9] M. Khamaisi,et al. Renal Parenchymal Hypoxia, Hypoxia Response and the Progression of Chronic Kidney Disease , 2008, American Journal of Nephrology.
[10] P. Prasad,et al. Blood oxygen level-dependent MR imaging of the kidneys. , 2008, Magnetic resonance imaging clinics of North America.
[11] S. Riederer,et al. The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. , 2008, Journal of the American Society of Nephrology : JASN.
[12] H. Krum,et al. Renal sympathetic-nerve ablation for uncontrolled hypertension. , 2009, The New England journal of medicine.
[13] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[14] W. Elliott. Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline , 2009 .
[15] H. Krum,et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial , 2010, The Lancet.
[16] W. J. Elliott,et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study , 2010 .
[17] L. Lerman,et al. Preserved Oxygenation Despite Reduced Blood Flow in Poststenotic Kidneys in Human Atherosclerotic Renal Artery Stenosis , 2010, Hypertension.
[18] Symplicity Htn Investigators,et al. Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension: Durability of Blood Pressure Reduction Out to 24 Months , 2011, Hypertension.
[19] Dominik Linz,et al. Renal Hemodynamics and Renal Function After Catheter-Based Renal Sympathetic Denervation in Patients With Resistant Hypertension , 2012, Hypertension.
[20] L. Lerman,et al. Compartmental Analysis of Renal BOLD MRI Data: Introduction and Validation , 2011, Investigative radiology.
[21] C. Tsioufis,et al. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial , 2013, European heart journal.
[22] Jeroen J. Bax,et al. 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.
[23] E. Vink,et al. Eligibility for percutaneous renal denervation: the importance of a systematic screening , 2013, Journal of hypertension.
[24] H. Krum,et al. Ambulatory Blood Pressure Changes After Renal Sympathetic Denervation in Patients With Resistant Hypertension , 2013, Circulation.
[25] J. Ormiston,et al. First-in-human use of the OneShot™ renal denervation system from Covidien. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[26] M. Uder,et al. Vascular and renal hemodynamic changes after renal denervation. , 2013, Clinical journal of the American Society of Nephrology : CJASN.
[27] T. Leiner,et al. Inhibition of the Renin‐Angiotensin System Affects Kidney Tissue Oxygenation Evaluated by Magnetic Resonance Imaging in Patients With Chronic Kidney Disease , 2014, Journal of clinical hypertension.